Balyasny Asset Management LLC Bristol Myers Squibb CO Call Options Transaction History

Balyasny Asset Management LLC

$58 Billion
Q3 2024

Call Options

16 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$39.66 - $51.75 $4.22 Million - $5.5 Million	106,300 New	106,300 $5.5 Million
Q4 2023 Feb 14, 2024	SELL	$48.48 - $57.85 $24.9 Million - $29.7 Million	-513,400 Reduced 98.11%	9,900 $507,000
Q3 2023 Nov 14, 2023	BUY	$57.89 - $64.73 $30.3 Million - $33.9 Million	523,300 New	523,300 $30.4 Million
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $27,651 - $16.3 Million	212,700 Added 595.8%	248,400 $17.7 Million
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $1.87 Million - $2.06 Million	25,700 Added 257.0%	35,700 $2.75 Million
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $75,082 - $87,528	-1,400 Reduced 12.28%	10,000 $624,000
Q2 2021 Aug 16, 2021	SELL	$61.91 - $67.42 $2.39 Million - $2.6 Million	-38,600 Reduced 77.2%	11,400 $762,000
Q1 2021 May 17, 2021	SELL	$59.34 - $66.74 $2.97 Million - $3.34 Million	-50,000 Reduced 50.0%	50,000 $3.16 Million
Q3 2019 Nov 14, 2019	SELL	$42.77 - $50.71 $37.4 Million - $44.4 Million	-875,000 Reduced 89.74%	100,000 $5.07 Million
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $37.9 Million - $45.2 Million	840,000 Added 622.22%	975,000 $46.5 Million
Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $23.4 Million - $30.4 Million	-480,000 Reduced 78.05%	135,000 $7.02 Million
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $29.7 Million - $33.5 Million	-538,000 Reduced 46.66%	615,000 $37.4 Million
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $69.7 Million - $86.9 Million	-1,379,500 Reduced 54.47%	1,153,000 $63.8 Million
Q1 2018 May 15, 2018	BUY	$59.92 - $68.98 $129 Million - $148 Million	2,152,500 Added 566.45%	2,532,500 $160 Million
Q4 2017 Feb 14, 2018	SELL	$59.94 - $65.35 $10.2 Million - $11.1 Million	-170,000 Reduced 30.91%	380,000 $23.3 Million
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $30.4 Million - $35.1 Million	550,000	550,000 $35.1 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$10.9 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.16 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.37 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.5 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.53 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account